<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/br.2019.1185</article-id>
<article-id pub-id-type="publisher-id">BR-0-0-1185</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Influence of nasal polyp tissue on the differentiation and activation of T lymphocytes in a co-culture system</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ickrath</surname><given-names>Pascal</given-names></name>
<xref rid="af1-br-0-0-1185" ref-type="aff">1</xref>
<xref rid="c1-br-0-0-1185" ref-type="corresp"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Scherzad</surname><given-names>Agmal</given-names></name>
<xref rid="af1-br-0-0-1185" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kleinsasser</surname><given-names>Norbert</given-names></name>
<xref rid="af2-br-0-0-1185" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ginzkey</surname><given-names>Chr</given-names></name>
<xref rid="af3-br-0-0-1185" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hagen</surname><given-names>Rudolf</given-names></name>
<xref rid="af1-br-0-0-1185" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hackenberg</surname><given-names>Stephan</given-names></name>
<xref rid="af1-br-0-0-1185" ref-type="aff">1</xref>
</contrib>
</contrib-group>
<aff id="af1-br-0-0-1185"><label>1</label>Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University of W&#x00FC;rzburg, D-97080 W&#x00FC;rzburg, Germany</aff>
<aff id="af2-br-0-0-1185"><label>2</label>Department of Otorhinolaryngology, Head and Neck Surgery, Kepler University Hospital, 4021 Linz, Austria</aff>
<aff id="af3-br-0-0-1185"><label>3</label>Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Otto Koerner Rostock University Medical Center, D-18057 Rostock, Germany</aff>
<author-notes>
<corresp id="c1-br-0-0-1185"><italic>Correspondence to</italic>: Dr Pascal Ickrath, Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University of W&#x00FC;rzburg, 11 Josef-Schneider-Str., D-97080 W&#x00FC;rzburg, Germany <email>ickrath_p@ukw.de</email></corresp>
<fn><p><italic>Abbreviations</italic>: CRS, chronic rhinosinusitis; CRSwNP, chronic rhinosinusitis with nasal polyps; CRSsNP, chronic rhinosinusitis without nasal polyps; T<sub>H</sub>, T helper; IL, interleukin; IL-6R, interleukin 6 receptor; CD, cluster of differentiation; CCR7, C-C motif chemokine receptor type 7; Foxp3, forkhead box P3; HLA, human leukocyte antigen; CTLA-4, cytotoxic T-lymphocyte associated protein 4; APC, antigen-presenting cell; GM-CSF, granulocyte-macrophage colony-stimulating factor; MIP-3, macrophage inflammatory protein-3; TGF-&#x03B2;, transforming growth factor-&#x03B2;; aT<sub>regs</sub>, activated regulatory T cells; rT<sub>regs</sub>, resting regulatory T cells; T<sub>conv</sub>, conventional T cells; DMEM, Dulbecco&#x0027;s modified Eagle&#x0027;s medium; FACS, fluorescence-activated cell sorting; Cy, Cyanine; IgG, immunoglobulin G; PE, phycoerythrin</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>02</month>
<year>2019</year></pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>01</month>
<year>2019</year></pub-date>
<volume>10</volume>
<issue>2</issue>
<fpage>119</fpage>
<lpage>126</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>06</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Pascal Ickrath et al.</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>Abstract: T cell subpopulations in nasal polyps differ from peripheral lymphocytes in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). However, little is known about the modulatory influence of the inflamed nasal polyp epithelial cells on the phenotype of the T cells. The aim of the present study was to assess this interaction. Tissue and blood samples were collected from 16 patients undergoing paranasal sinus surgery. Polypoid tissue was cultured under air-liquid interface conditions. Subsequently, cluster of differentiation (CD)3/CD28 activated peripheral lymphocytes from the same patients were added. After 3 days lymphocytes were separated from co-culture and analyzed by multicolor flow cytometry. Additionally, cytokine expression of the polyp tissue was measured using a human T helper cell (TH)1/T<sub>H</sub>2/T<sub>H</sub>17 antibody array. Viability staining of CD3<sup>+</sup> lymphocytes detected fewer apoptotic cells under co-culture conditions compared with in mono-culture. There was a significantly higher frequency of CD4<sup>+</sup> and CD8<sup>+</sup> T cells in the co-culture system than in PBMC culture alone. Human leukocyte antigen (HLA)-DR isotype was significantly downregulated on co-cultured CD3<sup>+</sup> lymphocytes and CD3<sup>+</sup>CD4<sup>+</sup> T cells compared with the mono-cultured counterparts. Conventional Forkhead box P3<sup>-</sup> memory CD4<sup>+</sup> T cells and activated regulatory T cells increased in frequency, and resting regulatory T cells decreased in the co-culture. Cytokine analysis identified expression of interleukin (IL)-6, IL-6 receptor, granulocyte-macrophage colony-stimulating factor, transforming growth factor-&#x03B2; and macrophage inflammatory protein-3 in the polyp tissue. In summary, the present study performed a comparison between peripheral lymphocytes cultured with and without nasal polyp tissue cells was performed. The downregulation of HLA and the differentiation of T<sub>reg</sub> and T<sub>conv</sub> by nasal polypoid tissue on PBMCs was demonstrated. Interestingly, the <italic>in vivo</italic> downregulation of HLA-DR on CD3<sup>+</sup> lymphocytes, as reported previously, was confirmed <italic>in vitro</italic>. The inhibitory effect of polypoid tissue on the activation of lymphocytes is a possible pathogenic mechanism underlying CRSwNP.</p>
</abstract>
<kwd-group>
<kwd>chronic rhinosinusitis with nasal polyps</kwd>
<kwd>chronic rhinosinusitis without nasal polyps</kwd>
<kwd>T cell subpopulations</kwd>
<kwd>co-culture system</kwd>
<kwd>air-liquid interface</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Chronic rhinosinusitis (CRS) is subdivided into two different phenotypes: Chronic rhinosinusitis with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP). The morbidity rate of CRS is relatively high, with 5-15% of the Caucasian population affected (<xref rid="b1-br-0-0-1185" ref-type="bibr">1</xref>). However, the etiopathology has remained unclear to date. Recently, study has further investigated the influence of lymphocytes, particularly T cells, and their contribution to maintaining the chronic inflammation of the mucosa. The findings led to a different classification of inflammatory endotypes (<xref rid="b2-br-0-0-1185" ref-type="bibr">2</xref>). CRSwNP is characterized by a T helper (TH)2, and CRSsNP by a mixed T<sub>H</sub>1 and T<sub>H</sub>17 inflammatory response, though previous data shows heterogeneous cell types in both endotypes with a predominant inflammation type (<xref rid="b3-br-0-0-1185" ref-type="bibr">3</xref>). In nasal polyps, the inflammatory process is primarily modulated by the expression of interleukin (IL)-4, -5 and -13(<xref rid="b4-br-0-0-1185" ref-type="bibr">4</xref>). Peters <italic>et al</italic> (<xref rid="b5-br-0-0-1185" ref-type="bibr">5</xref>) additionally detected significantly increased levels of IL-6 in CRSwNP, as a further potential pathogenic signaling pathway in this disease. Furthermore, a switch from mainly cluster of differentiation (CD)4<sup>+</sup> T cells in peripheral blood to CD8<sup>+</sup> T cells in nasal polyps in patients with CRSwNP has been demonstrated (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>). Both subpopulations exhibited a significant increase in effector T cells (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>). According to the classification of Miyara <italic>et al</italic> (<xref rid="b7-br-0-0-1185" ref-type="bibr">7</xref>), a significant increase in activated regulatory T cells (aT<sub>regs</sub>) and conventional Forkhead box P3 (Foxp3<sub>low</sub>) memory T cells (T<sub>conv</sub>) was identified in nasal polyps compared with in peripheral blood in patients with CRSwNP (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>).</p>
<p>Human barrier models are already well established and frequently used for immunological <italic>in vitro</italic> studies (8-11). Due to their effective illustration of the <italic>in vivo</italic> situation they are useful for avoiding animal testing (<xref rid="b8-br-0-0-1185" ref-type="bibr">8</xref>). Mechanistic papers have depicted the generation of an air-liquid interface model (<xref rid="b9-br-0-0-1185" ref-type="bibr">9</xref>), confirmed the similarity of <italic>in vitro</italic> air-liquid interface models to <italic>in vivo</italic> models (<xref rid="b10-br-0-0-1185" ref-type="bibr">10</xref>) and demonstrated a mucin production in the air-liquid interface equal to normal sputum (<xref rid="b11-br-0-0-1185" ref-type="bibr">11</xref>). Certain authors have investigated the influence of cell lines, for instance tumor cells (<xref rid="b12-br-0-0-1185" ref-type="bibr">12</xref>) or retinal pigment cells (<xref rid="b13-br-0-0-1185" ref-type="bibr">13</xref>), in a co-culture system to determine their phenotype modulation by fibroblasts (<xref rid="b12-br-0-0-1185" ref-type="bibr">12</xref>) or T cells (<xref rid="b13-br-0-0-1185" ref-type="bibr">13</xref>). Steelant <italic>et al</italic> (<xref rid="b14-br-0-0-1185" ref-type="bibr">14</xref>) used a co-culture system to measure the epithelial dysfunction in allergic rhinitis. All these studies demonstrate the effectiveness of co-culture systems to assess the influence of one cell type on an other cell type.</p>
<p>The question arises if nasal polyp tissue itself is responsible for the consistency of the inflammatory reaction in CRSwNP. The purpose of the current study was to detect the direct influence of the nasal polyp tissue on the differentiation or activation of lymphocytes via the secretion of cytokines. The current study has hypothesized that a major difficulty of T cell investigation in multicolor flow cytometry analysis is the low quantity of these cells within polyp tissue. To circumvent this problem, a co-culture system was developed with nasal polyp tissue and peripheral lymphocytes. Additionally, the cytokine expression of the polyp tissue was measured, since this is responsible for the T cell responses in this system.</p>
</sec>
<sec sec-type="Materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Preparation of human lymphocytes</title>
<p>Heparinized blood samples (10 ml) were obtained intraoperatively by venous puncture from 16 patients (mean age, 51.80&#x00B1;18.12; sex ratio, 6:10 female:male) undergoing paranasal sinus surgery between March 2016 and March 2017. Patients were recruited from the Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery at the University of W&#x00FC;rzburg, W&#x00FC;rzburg, Germany. Diagnosis of nasal polyposis and indication for surgery was determined according to the European Position Paper on Rhinosinusitus and Nasal Polyps 2012 guidelines (<xref rid="b1-br-0-0-1185" ref-type="bibr">1</xref>). Patients with Churg-Strauss syndrome, primary ciliary dyskinesia or cystic fibrosis were excluded. The study was approved by the Ethics Board of the Medical Faculty of Julius-Maximilian-University, W&#x00FC;rzburg, Germany (approval no. 16/06), and written informed consent was obtained from all patients.</p>
<p>Peripheral lymphocytes were separated by density-gradient centrifugation for 10 min at 1,000 x g at room temperature with 3 ml of Ficoll (Biochrom GmbH, Berlin, Germany), using a membrane-containing 10 ml cell tube (Greiner Bio-One, Kremsm&#x00FC;nster, Austria). Tubes were washed twice with phosphate-buffered saline and cell number and viability were determined using a Cell Counter+ Analyzer System (CASY TT; Innovatis Technologies, Inc., Fairfax, VA, USA) according to the manufacturer&#x0027;s protocol. Following centrifugation at 500 x g at 20&#x02DA;C for 5 min, cells were transferred into 1 ml freezing medium, which contained 10 parts fetal bovine serum (Linaris GmbH, Dossenheim, Germany) and one part dimethylsulfoxide. The cell suspension was then stored at -80&#x02DA;C.</p>
</sec>
<sec>
<title>Isolation and cultivation of human nasal polypoid tissue cells</title>
<p>All polypoid tissue samples were collected intraoperatively from the same 16 patients undergoing standard paranasal sinus surgery due to CRSwNP as described above. Isolation and cultivation of the cells were performed as previously reported (<xref rid="b15-br-0-0-1185" ref-type="bibr">15</xref>,<xref rid="b16-br-0-0-1185" ref-type="bibr">16</xref>). Following isolation, the polypoid tissue cells were cultured on porous membrane inserts (Corning Transwell polycarbonate membrane inserts, 0.4 <italic>&#x00B5;</italic>m pore size, 12 mm diameter; Corning Incorporated, Corning, NY, USA) and covered with 150 <italic>&#x00B5;</italic>l collagen I (66 ng/ml; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). Culture medium was refreshed every second day. After reaching 70-80% confluence on day 7, the medium apical to the membrane was removed, and nutrition was provided to the cells by adding 1.3 ml Airway Epithelial Cell Medium (PromoCell GmbH, Heidelberg, Germany) per insert under the membrane. At this point, the cultures reached an air-liquid interface condition, which was maintained from day 7 to 14 to stabilize the culture conditions. Subsequently, basal cell medium was removed and a cytokine-free medium was added, which contained 7.5 ml Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM)/F12 and 7.5 ml DMEM-low glucose supplemented with bovine serum albumin (0.4 g albumin/100 ml medium; all from PAA Laboratories, Inc.; GE Healthcare Life Sciences, Little Chalfont, UK), as previously described (<xref rid="b12-br-0-0-1185" ref-type="bibr">12</xref>). Peripheral lymphocytes from the same patients were activated with Dynabeads&#x2122; Human T-Activator CD3/CD28 (111161D; Gibco&#x2122;; Thermo Fisher Scientific Inc., Waltham, MA, USA) according to the manufacturer&#x0027;s protocol, and 1x106 cells were inserted into the basal compartment. After 3 days in co-culture at 37&#x02DA;C, lymphocytes within the basal compartment were removed and flow cytometry analysis was performed. As a control, peripheral lymphocytes from the same patient were cultured without the Transwell insert in a mono-culture system.</p>
</sec>
<sec>
<title>Measurement of cytokine secretion from polypoid tissue under air-liquid interface conditions</title>
<p>Polypoid tissue of 4 patients was cultured according to the method described above, without the peripheral lymphocytes in the basal layers. After 3 days, supernatants were collected and a T<sub>H</sub>1/T<sub>H</sub>2/T<sub>H</sub>17 human cytokine array (AAH-TH17-1-2; RayBiotech, Inc., Norcross, GA, USA) with 34 possible targets was performed according to the manufacturer&#x0027;s protocol. Densities of the dot plots were measured by ImageJ v.1.50 (National Institutes of Health, Bethesda, MD, USA).</p>
</sec>
<sec>
<title>Fluorescence-activated cell sorting (FACS)</title>
<p>The following antibodies were used: Anti-CD45 Pacific Orange (1:300; MHCD4530; Thermo Fisher Scientific, Inc.), anti-CD3 phycoerythrin (PE)-Cyanine (Cy)7 (1:300; 300420) anti-CD4 Pacific Blue (1:50; 300521), anti-CD8a Alexa 700 (1:50; 301028), anti-CD45RA peridinin chlorophyll protein complex-Cy5.5 (1:50; 304122), anti-CCR7 Alexa488 (1:80; 353206), anti-CD4 fluorescein isothiocyanate (1:40; 300506), anti-FoxP3 Pacific Blue (1:25; 320216), anti-human leukocyte antigen (HLA)-DR isotype (AlexaFluor 700; 1:25; 307626), anti-CD52 [also known as cytotoxic T-lymphocyte associated protein 4 (CTLA-4)] PE (1:400; 349906; all from BioLegend, Inc., San Diego, CA, USA) and anti-Ki-67 (1:200; 556027; BD Biosciences, San Jose, CA, USA). Isotype control staining was performed using mouse-immunoglobulin G (IgG) antigen-presenting cell (APC; 1:80; 137214; BioLegend, Inc.) and mouse-IgG PE (1:25; 556027; BD Biosciences). Viability Dye 780 (1:10; 65-0865-14; eBioscience; Thermo Fisher Scientific Inc.) was used to detect apoptotic and dead cells. Following blocking with 25 <italic>&#x00B5;</italic>g/ml normal mouse IgG (1:50; I5381; Sigma-Aldrich; Merck KGaA) for 15 min on ice, all cells underwent cell surface staining on ice for 30 min, followed by intracellular staining. For intracellular staining of Ki-67, Foxp3 and CTLA-4, cells were treated with 100 <italic>&#x00B5;</italic>l fixation buffer (eBioscience; Thermo Fisher Scientific, Inc.) per well for 30 min at room temperature. Permeabilization buffer (200 <italic>&#x00B5;</italic>l) was subsequently applied (eBioscience; Thermo Fisher Scientific, Inc.) followed by staining with anti-Foxp3, anti-CTLA-4 and anti-Ki-67 for 45 min at room temperature. All antibodies were used according to the manufacturer&#x0027;s protocol. FACS analysis was performed using an LSR II flow cytometer and the data were analyzed using FlowJo 10.2 software (FlowJo LLC, Ashland, OR, USA).</p>
</sec>
<sec>
<title>Statistics</title>
<p>Data are presented as the mean &#x00B1; standard deviation. The statistical significance of data was determined by two-tailed paired t-tests using GraphPad Prism software 6.0c (GraphPad Software, Inc., La Jolla, CA, USA). For data with non-parametric distribution, the Wilcoxon test was applied. Values with P&#x003C;0.05 were considered statistically significant in all comparisons.</p>
</sec>
</sec>
</sec>
<sec sec-type="Results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Cytokine secretion from polypoid tissue under air-liquid interface conditions</title>
<p>Cytokine secretion of air-liquid interface polypoid tissue cultures was semi-quantitatively measured after 3 days with a T<sub>H</sub>1/T<sub>H</sub>2/T<sub>H</sub>17 antibody array. A secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-6, IL-6 receptor (IL-6R), macrophage inflammatory protein-3 (MIP-3) and transforming growth factor-&#x03B2; (TGF-&#x03B2;) was identified (<xref rid="f1-br-0-0-1185" ref-type="fig">Fig. 1</xref>).</p>
</sec>
<sec>
<title>Viability of lymphocytes under co-culture conditions</title>
<p>Overall, the viability of CD45<sup>+</sup> and CD3<sup>+</sup> lymphocytes was significantly decreased under mono-culture conditions, compared with that of the co-cultured control group (viable cell rate, 52.70&#x00B1;19.42 vs. 66.43&#x00B1;30.83%, respectively; P&#x003C;0.05; <xref rid="f2-br-0-0-1185" ref-type="fig">Fig. 2A-C</xref>). Furthermore, the percentage of viable CD3<sup>+</sup>CD4<sup>+</sup> (<xref rid="f2-br-0-0-1185" ref-type="fig">Fig. 2D</xref>) and CD3<sup>+</sup>CD8<sup>+</sup> T cells (<xref rid="f2-br-0-0-1185" ref-type="fig">Fig. 2E</xref>) was significantly higher in the co-culture (P=0.02 and P=0.008, respectively; <xref rid="tI-br-0-0-1185" ref-type="table">Table I</xref>). Between these two subsets, CD4<sup>+</sup> T cells were the dominant subpopulation in both the co-culture and mono-culture (<xref rid="tI-br-0-0-1185" ref-type="table">Table I</xref>).</p>
</sec>
<sec>
<title>No changes in the differentiation of CD3<sup>+</sup>CD4<sup>+</sup> and CD3<sup>+</sup>CD8<sup>+</sup> T cell subpopulations</title>
<p>CD3<sup>+</sup>CD4<sup>+</sup> and CD3<sup>+</sup>CD8<sup>+</sup> T cell subpopulations were analyzed via staining of CD45RA and CCR7. The analysis of CD3<sup>+</sup>CD4<sup>+</sup> T cells identified no significant difference in the frequency of CCR7<sup>+</sup>CD45RA<sup>+</sup> na&#x00EF;ve, CCR7<sup>+</sup>CD45<sup>-</sup> central memory, CCR7<sup>-</sup>CD45RA<sup>-</sup> effector memory or CCR7<sup>-</sup>CD45RA<sup>+</sup> terminally differentiated T cells (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>) between mono- and co-culture (<xref rid="tI-br-0-0-1185" ref-type="table">Table I</xref>). Effector memory T cells were the major subpopulation under co- and mono-culture. Also among CD3<sup>+</sup>CD8<sup>+</sup> T cell subpopulations, no differences were detected, and effector memory T cells were again the dominant subpopulation in both groups (<xref rid="tI-br-0-0-1185" ref-type="table">Table I</xref>).</p>
</sec>
<sec>
<title>Significant increases in aT<sub>reg</sub> and T<sub>conv</sub> and decrease in resting (r)T<sub>reg</sub> cells under co-culture conditions</title>
<p>Further determination of CD3<sup>+</sup>CD4<sup>+</sup> T cell subpopulations by staining for Foxp3 and CD45RA revealed differences between mono- and co-culture (<xref rid="f3-br-0-0-1185" ref-type="fig">Fig. 3A</xref>). The frequency of Foxp3<sup>-</sup>CD45RA<sup>-</sup> T cells (T<sub>conv</sub>) (<xref rid="b7-br-0-0-1185" ref-type="bibr">7</xref>) was significantly higher in co-culture than among mono-cultured lymphocytes (P=0.01; <xref rid="tII-br-0-0-1185" ref-type="table">Table II</xref>). The co-cultured lymphocytes also exhibited significantly increased aT<sub>regs</sub> (CD45RA-FoxP3<sup>high</sup>CTLA-4<sup>high</sup>; P=0.04) and significantly decreased rT<sub>regs</sub> (CD45RA<sup>+</sup>Foxp3<sup>low</sup>CTLA-4<sup>low</sup>; P=0.01) (<xref rid="b7-br-0-0-1185" ref-type="bibr">7</xref>) than under mono-cultured conditions. No differences in the frequencies of na&#x00EF;ve CD45RA<sup>+</sup> FoxP3<sup>-</sup> and nonsuppressive CD45RA<sup>-</sup> Foxp3<sup>low</sup> T<sub>conv</sub> (<xref rid="b7-br-0-0-1185" ref-type="bibr">7</xref>) were determined. In mono- and co-culture, the majority of the CD3<sup>+</sup>CD4<sup>+</sup> T cells were na&#x00EF;ve CD45RA<sup>+</sup>FoxP3<sup>-</sup> T cells (<xref rid="tII-br-0-0-1185" ref-type="table">Table II</xref>).</p>
</sec>
<sec>
<title>Significant downregulation of HLA-DR on CD3<sup>+</sup> and CD3<sup>+</sup>CD4<sup>+</sup> T cells under co-culture conditions</title>
<p>The activation marker HLA-DR (<xref rid="b17-br-0-0-1185" ref-type="bibr">17</xref>) was significantly downregulated on CD3<sup>+</sup> lymphocytes (P=0.01) and CD3<sup>+</sup>CD4<sup>+</sup> T cells (<xref rid="f3-br-0-0-1185" ref-type="fig">Fig. 3B</xref>; P=0.0002) on co-cultured compared with mono-cultured lymphocytes (<xref rid="tIII-br-0-0-1185" ref-type="table">Table III</xref>). HLA-DR expression detection was not performed on CD8<sup>+</sup> T cells, due to the multicolor flow cytometry panel utilized. Meanwhile, the expression of the intracellular proliferation marker Ki-67(<xref rid="b18-br-0-0-1185" ref-type="bibr">18</xref>) was also measured. No differences in expression were observed among CD3<sup>+</sup>, CD4<sup>+</sup> and CD8<sup>+</sup> T cells between mono- and co-culture (<xref rid="tIII-br-0-0-1185" ref-type="table">Table III</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>The current study determined differences in the activation and differentiation of peripheral T cell subpopulations following co-culture with nasal polyp tissue cells. Epithelial cells from nasal polyps were cultured under air-liquid interface conditions and a expression of cytokines, particularly IL-6, IL-6R, GM-CSF, MIP-3 and TGF-&#x03B2;, was measured. This respiratory epithelial cell culture under air-liquid interface conditions is widely used in airway research due to a high functional and morphological <italic>in vivo-in vitro</italic> correlation (<xref rid="b19-br-0-0-1185 b20-br-0-0-1185 b21-br-0-0-1185" ref-type="bibr">19-21</xref>).</p>
<p>Mucociliary differentiation of nasal epithelial cells has been described for regular nasal mucosa (<xref rid="b19-br-0-0-1185" ref-type="bibr">19</xref>) and nasal polyps (<xref rid="b20-br-0-0-1185" ref-type="bibr">20</xref>). De Borja Callejas <italic>et al</italic> (<xref rid="b21-br-0-0-1185" ref-type="bibr">21</xref>) described a 3D <italic>in vitro</italic> model for nasal polyposis, which is similar to the air-liquid interface model used in the present study. They also showed a time-dependent mucociliary differentiation of epithelial cells derived from nasal polyps which were cultivated under air-liquid interface conditions. Furthermore, they described increased levels of pro-inflammatory cytokines such as IL-8 and GM-CSF compared with control nasal mucosa under monolayer culture conditions. Increased GM-CSF levels have been described <italic>in vivo</italic> in patients with an acute CRSwNP exacerbation (<xref rid="b22-br-0-0-1185" ref-type="bibr">22</xref>). Besides GM-CSF, high levels of IL-6 and IL-6R were also detected in the present study. Several studies have highlighted the pro-inflammatory role of IL-6 in patients with CRSwNP and reported on significantly increased tissue levels of IL-6 (<xref rid="b5-br-0-0-1185" ref-type="bibr">5</xref>,<xref rid="b22-br-0-0-1185" ref-type="bibr">22</xref>) and IL-6R (<xref rid="b5-br-0-0-1185" ref-type="bibr">5</xref>). IL-6 and its specific receptor IL-6R appear to serve a crucial role in CRSwNP (<xref rid="b5-br-0-0-1185" ref-type="bibr">5</xref>), and its signaling pathway is important for T cell recruitment and survival, particularly in preventing apoptosis, preventing the differentiation of T<sub>regs</sub>, and in retaining T cells in the local tissue (<xref rid="b5-br-0-0-1185" ref-type="bibr">5</xref>,<xref rid="b23-br-0-0-1185" ref-type="bibr">23</xref>). Consistent with the presented <italic>in vitro</italic> study, increased levels of MIP-3 (<xref rid="b24-br-0-0-1185" ref-type="bibr">24</xref>,<xref rid="b25-br-0-0-1185" ref-type="bibr">25</xref>) and TGF-&#x03B2; (<xref rid="b26-br-0-0-1185" ref-type="bibr">26</xref>) have been identified <italic>in vivo</italic> in patients with CRSwNP. In summary, these findings underscore the reliability of the air-liquid interface model with epithelial cells from nasal polyps and its validity for further immunological studies.</p>
<p>Co-cultured peripheral lymphocytes were significantly more viable and higher frequencies of CD4<sup>+</sup> and CD8<sup>+</sup> T cells were measured. The secretion of growth factors by the epithelial cells, particularly IL-6, as described above is likely to mediate these findings. This supports the hypothesis that polypoid tissue itself is responsible for maintaining the inflammatory reaction. However, further analysis of T cell subpopulations determined no differences between na&#x00EF;ve, central memory, effector memory and terminally differentiated CD4<sup>+</sup> and CD8<sup>+</sup> T cells compared with mono-cultured peripheral lymphocytes. In mono- and co-culture, effector memory T cells were the major subpopulation among CD4<sup>+</sup> and CD8<sup>+</sup> T cells, followed by terminally differentiated and na&#x00EF;ve cells. The subpopulation with the lowest frequency was central memory T cells in both culture conditions. Previous studies have demonstrated differences in CD4<sup>+</sup> and CD8<sup>+</sup> T cell subpopulations with differentiation from mostly na&#x00EF;ve T cells in peripheral blood lymphocytes to T cells with an effector memory phenotype in lymphocytes from peripheral blood (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>,<xref rid="b27-br-0-0-1185" ref-type="bibr">27</xref>). Due to the absence of APCs in the <italic>in vitro</italic> model, cells had to be stimulated by CD3/CD28 prior to adding them to the co-culture. This compromises the direct comparison to <italic>in vivo</italic> findings, but it appears that polypoid tissue has no immediate influence on the differentiation of T cell subpopulations. Perhaps long-term co-culturing would induce such differences, but in this case, an additional substitution of IL-2 to the basal medium is necessary to support survival of the lymphocytes beyond the period of 3 days.</p>
<p>In a study by Miyara <italic>et al</italic> (<xref rid="b7-br-0-0-1185" ref-type="bibr">7</xref>), further analysis of CD4<sup>+</sup> T cell differentiation into na&#x00EF;ve FoxP3<sup>-</sup> and Foxp3<sup>low</sup> T<sub>conv</sub>, aT<sub>regs</sub> and rT<sub>regs</sub> was performed. Interestingly, aT<sub>regs</sub> and FoxP3<sup>-</sup> T<sub>conv</sub> significantly increased and rT<sub>regs</sub> significantly decreased in the co-culture compared with a mono-culture system. These finding are similar to a previous <italic>in vivo</italic> study by our group, where a significant increase in aT<sub>regs</sub> and FoxP3<sup>-</sup> T<sub>conv</sub> was also identified (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>). The current study hypothesizes that the differentiation of rT<sub>regs</sub> to aT<sub>regs</sub> may be classified as a feedback mechanism in response to inflammatory stimulation of the nasal polyp epithelial cells. The role of memory T cells such as FoxP3<sup>-</sup> T<sub>conv</sub> is of particular interest (<xref rid="b28-br-0-0-1185" ref-type="bibr">28</xref>,<xref rid="b29-br-0-0-1185" ref-type="bibr">29</xref>), and seems to be responsible for an immediate defense against viruses or bacterial infection (<xref rid="b30-br-0-0-1185" ref-type="bibr">30</xref>). Taken together, the data suggests that nasal polyp epithelium mediates the immediate memory T cell recruitment.</p>
<p>The intensity of T cell activation was measured by evaluating the expression of HLA-DR and Ki-67. A significant decrease in HLA-DR on CD3<sup>+</sup> and CD4<sup>+</sup> lymphocytes in the co-culture compared with in the mono-culture was detected. There were no differences in the expression of the intracellular proliferation marker Ki-67. A lack of HLA-DR upregulation on CD3<sup>+</sup> lymphocytes was similarly measured previously <italic>in vivo</italic> (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>), and thus it appears that the nasal polyp epithelium is not responsible for reactivation of T cells in the tissue. Interestingly, the expression of HLA-DR significantly decreased in the presence of nasal polyp epithelium cells.</p>
<p>CRS is a heterogeneous group of varying diseases, and subclassifications attempt to structure the variety of manifestations according to pathophysiological parameters. T cells appear to serve a major role in the development of polyps (<xref rid="b3-br-0-0-1185" ref-type="bibr">3</xref>). However, the communication between epithelium and the T cell infiltrate is yet to be fully understood. Results of the current study suggest that there exists such an intercellular communication. The epithelium may promote T cell survival within the tissue by the secretion of various cytokines. One of the most notable findings of the current study was that nasal epithelial cells were able to modify T cell subsets similarly to the situation observed <italic>in vivo</italic> (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>). Hence, it hypothesized that the air-liquid interface co-culture model imitates the functional aspects of the above-mentioned cell-cell communication, and is thus a suitable tool for research on airway immunology. However, there are several limitations to the present study. The use of peripheral blood lymphocytes does not match the <italic>in vivo</italic> situation exactly. It would be more appropriate to use local tissue-resident T cells from unaffected nasal mucosa and submucosa. However, the number of T cells available under healthy conditions is markedly low, so that a large quantity of mucosal tissues would need to be collected. Furthermore, previous study has also compared polyp-associated T cells with peripheral blood T cells (<xref rid="b6-br-0-0-1185" ref-type="bibr">6</xref>), and there is notable variability between the individual results. The present study was declared as a pilot project with a limited amount of samples. Regarding research using primary cells, high interindividual variations have to be tolerated, and, in addition to this, cells are not immortalized or transformed (<xref rid="b31-br-0-0-1185" ref-type="bibr">31</xref>,<xref rid="b32-br-0-0-1185" ref-type="bibr">32</xref>). A previous activation of peripheral lymphocytes was necessary in the current study due to the absence of APCs in the co-culture system. This may also influence the results; however, we believe that this fact is likely to be insignificant. The air-liquid interface is able to imitate the effects of cytokines derived from epithelial cells on T lymphocytes, which is considered to be the most important mode of communication (<xref rid="b15-br-0-0-1185" ref-type="bibr">15</xref>). However, various settings involving direct contact of lymphocytes with epithelial cells should also be measured. Finally, little is known about the opposite effect, and future studies should focus on the possibility of inducing epithelial cell transformation following co-cultivation with T cells derived from CRSwNP patients.</p>
<p>In conclusion, the present study underscores the influence of nasal polyp epithelial cells in maintaining the inflammatory reaction by expressing pro-inflammatory cytokines and preventing T cells from apoptosis. Furthermore, the study results support that the air-liquid interface co-culture is an appropriate standardized and reliable model for analyzing the contribution of nasal polyp epithelium cells to the etiopathology of CRSwNP.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank Niklas Beyersdorf for providing advice on the methods used. This study was presented in an abstract at the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN) Mar 30 - Apr 01, 2017 in D&#x00FC;sseldorf, Germany and published as abstract no. S330 in Laryngo-Rhino-Otol 97 (S 02): 2018.</p>
</ack>
<sec>
<title>Funding</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>All data generated or analyzed during this study are included in this published article.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>PI was principally responsible for drafting the manuscript and performed, analyzed and interpreted all experiments. AS, NK, RH and CG aided to analyze the data and were major contributors to the writing of the manuscript. SH was involved in the selection, analysis and interpretation of the experiments and was a major contributor to the writing of the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The study was approved by the Ethics Board of the Medical Faculty of Julius-Maximilian-University, W&#x00FC;rzburg, Germany (approval no. 16/06). Written informed consent was obtained from each participating patient.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Written informed consent was obtained from all patients for the publication of their associated data.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-br-0-0-1185"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fokkens</surname><given-names>WJ</given-names></name><name><surname>Lund</surname><given-names>VJ</given-names></name><name><surname>Mullol</surname><given-names>J</given-names></name><name><surname>Bachert</surname><given-names>C</given-names></name><name><surname>Alobid</surname><given-names>I</given-names></name><name><surname>Baroody</surname><given-names>F</given-names></name><name><surname>Cohen</surname><given-names>N</given-names></name><name><surname>Cervin</surname><given-names>A</given-names></name><name><surname>Douglas</surname><given-names>R</given-names></name><name><surname>Gevaert</surname><given-names>P</given-names></name><etal/></person-group><article-title>European Position Paper on Rhinosinusitis and Nasal Polyps 2012</article-title><source>Rhinol Suppl</source><volume>23</volume><issue>3</issue><year>2012</year><pub-id pub-id-type="pmid">22764607</pub-id></element-citation></ref>
<ref id="b2-br-0-0-1185"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomassen</surname><given-names>P</given-names></name><name><surname>Vandeplas</surname><given-names>G</given-names></name><name><surname>Van Zele</surname><given-names>T</given-names></name><name><surname>Cardell</surname><given-names>LO</given-names></name><name><surname>Arebro</surname><given-names>J</given-names></name><name><surname>Olze</surname><given-names>H</given-names></name><name><surname>F&#x00F6;rster-Ruhrmann</surname><given-names>U</given-names></name><name><surname>Kowalski</surname><given-names>ML</given-names></name><name><surname>Olszewska-Zi&#x0105;ber</surname><given-names>A</given-names></name><name><surname>Holtappels</surname><given-names>G</given-names></name><etal/></person-group><article-title>Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers</article-title><source>J Allergy Clin Immunol</source><volume>137</volume><fpage>1449</fpage><lpage>56</lpage><comment>e4</comment><year>2016</year><pub-id pub-id-type="pmid">26949058</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2015.12.1324</pub-id></element-citation></ref>
<ref id="b3-br-0-0-1185"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derycke</surname><given-names>L</given-names></name><name><surname>Eyerich</surname><given-names>S</given-names></name><name><surname>Van Crombruggen</surname><given-names>K</given-names></name><name><surname>P&#x00E9;rez-Novo</surname><given-names>C</given-names></name><name><surname>Holtappels</surname><given-names>G</given-names></name><name><surname>Deruyck</surname><given-names>N</given-names></name><name><surname>Gevaert</surname><given-names>P</given-names></name><name><surname>Bachert</surname><given-names>C</given-names></name></person-group><article-title>Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps</article-title><source>PLoS One</source><volume>9</volume><issue>e97581</issue><year>2014</year><pub-id pub-id-type="pmid">24911279</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0097581</pub-id></element-citation></ref>
<ref id="b4-br-0-0-1185"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Zele</surname><given-names>T</given-names></name><name><surname>Claeys</surname><given-names>S</given-names></name><name><surname>Gevaert</surname><given-names>P</given-names></name><name><surname>Van Maele</surname><given-names>G</given-names></name><name><surname>Holtappels</surname><given-names>G</given-names></name><name><surname>Van Cauwenberge</surname><given-names>P</given-names></name><name><surname>Bachert</surname><given-names>C</given-names></name></person-group><article-title>Differentiation of chronic sinus diseases by measurement of inflammatory mediators</article-title><source>Allergy</source><volume>61</volume><fpage>1280</fpage><lpage>1289</lpage><year>2006</year><pub-id pub-id-type="pmid">17002703</pub-id><pub-id pub-id-type="doi">10.1111/j.1398-9995.2006.01225.x</pub-id></element-citation></ref>
<ref id="b5-br-0-0-1185"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>AT</given-names></name><name><surname>Kato</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Conley</surname><given-names>DB</given-names></name><name><surname>Suh</surname><given-names>L</given-names></name><name><surname>Tancowny</surname><given-names>B</given-names></name><name><surname>Carter</surname><given-names>D</given-names></name><name><surname>Carr</surname><given-names>T</given-names></name><name><surname>Radtke</surname><given-names>M</given-names></name><name><surname>Hulse</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps</article-title><source>J Allergy Clin Immunol</source><volume>125</volume><fpage>397</fpage><lpage>403</lpage><comment>e10</comment><year>2010</year><pub-id pub-id-type="pmid">20159251</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2009.10.072</pub-id></element-citation></ref>
<ref id="b6-br-0-0-1185"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ickrath</surname><given-names>P</given-names></name><name><surname>Kleinsasser</surname><given-names>N</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Ginzkey</surname><given-names>C</given-names></name><name><surname>Beyersdorf</surname><given-names>N</given-names></name><name><surname>Hagen</surname><given-names>R</given-names></name><name><surname>Kerkau</surname><given-names>T</given-names></name><name><surname>Hackenberg</surname><given-names>S</given-names></name></person-group><article-title>Characterization of T-cell subpopulations in patients with chronic rhinosinusitis with nasal polyposis</article-title><source>Allergy Rhinol (Providence)</source><volume>8</volume><fpage>139</fpage><lpage>147</lpage><year>2017</year><pub-id pub-id-type="pmid">29070271</pub-id><pub-id pub-id-type="doi">10.2500/ar.2017.8.0214</pub-id></element-citation></ref>
<ref id="b7-br-0-0-1185"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyara</surname><given-names>M</given-names></name><name><surname>Yoshioka</surname><given-names>Y</given-names></name><name><surname>Kitoh</surname><given-names>A</given-names></name><name><surname>Shima</surname><given-names>T</given-names></name><name><surname>Wing</surname><given-names>K</given-names></name><name><surname>Niwa</surname><given-names>A</given-names></name><name><surname>Parizot</surname><given-names>C</given-names></name><name><surname>Taflin</surname><given-names>C</given-names></name><name><surname>Heike</surname><given-names>T</given-names></name><name><surname>Valeyre</surname><given-names>D</given-names></name><etal/></person-group><article-title>Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor</article-title><source>Immunity</source><volume>30</volume><fpage>899</fpage><lpage>911</lpage><year>2009</year><pub-id pub-id-type="pmid">19464196</pub-id><pub-id pub-id-type="doi">10.1016/j.immuni.2009.03.019</pub-id></element-citation></ref>
<ref id="b8-br-0-0-1185"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweinlin</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Lodes</surname><given-names>N</given-names></name><name><surname>Lotz</surname><given-names>C</given-names></name><name><surname>Hackenberg</surname><given-names>S</given-names></name><name><surname>Steinke</surname><given-names>M</given-names></name><name><surname>Walles</surname><given-names>H</given-names></name><name><surname>Groeber</surname><given-names>F</given-names></name></person-group><article-title>Human barrier models for the in vitro assessment of drug delivery</article-title><source>Drug Deliv Transl Res</source><volume>7</volume><fpage>217</fpage><lpage>227</lpage><year>2017</year><pub-id pub-id-type="pmid">27549106</pub-id><pub-id pub-id-type="doi">10.1007/s13346-016-0316-9</pub-id></element-citation></ref>
<ref id="b9-br-0-0-1185"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everman</surname><given-names>JL</given-names></name><name><surname>Rios</surname><given-names>C</given-names></name><name><surname>Seibold</surname><given-names>MA</given-names></name></person-group><article-title>Utilization of air-liquid interface cultures as an in vitro model to assess primary airway epithelial cell responses to the type 2 cytokine interleukin-13</article-title><source>Methods Mol Biol</source><volume>1799</volume><fpage>419</fpage><lpage>432</lpage><year>2018</year><pub-id pub-id-type="pmid">29956168</pub-id><pub-id pub-id-type="doi">10.1007/978-1-4939-7896-0_30</pub-id></element-citation></ref>
<ref id="b10-br-0-0-1185"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezzulo</surname><given-names>AA</given-names></name><name><surname>Starner</surname><given-names>TD</given-names></name><name><surname>Scheetz</surname><given-names>TE</given-names></name><name><surname>Traver</surname><given-names>GL</given-names></name><name><surname>Tilley</surname><given-names>AE</given-names></name><name><surname>Harvey</surname><given-names>BG</given-names></name><name><surname>Crystal</surname><given-names>RG</given-names></name><name><surname>McCray</surname><given-names>PB Jr</given-names></name><name><surname>Zabner</surname><given-names>J</given-names></name></person-group><article-title>The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>300</volume><fpage>L25</fpage><lpage>L31</lpage><year>2011</year><pub-id pub-id-type="pmid">20971803</pub-id><pub-id pub-id-type="doi">10.1152/ajplung.00256.2010</pub-id></element-citation></ref>
<ref id="b11-br-0-0-1185"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesimer</surname><given-names>M</given-names></name><name><surname>Kirkham</surname><given-names>S</given-names></name><name><surname>Pickles</surname><given-names>RJ</given-names></name><name><surname>Henderson</surname><given-names>AG</given-names></name><name><surname>Alexis</surname><given-names>NE</given-names></name><name><surname>Demaria</surname><given-names>G</given-names></name><name><surname>Knight</surname><given-names>D</given-names></name><name><surname>Thornton</surname><given-names>DJ</given-names></name><name><surname>Sheehan</surname><given-names>JK</given-names></name></person-group><article-title>Tracheobronchial air-liquid interface cell culture: A model for innate mucosal defense of the upper airways?</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>296</volume><fpage>L92</fpage><lpage>L100</lpage><year>2009</year><pub-id pub-id-type="pmid">18931053</pub-id><pub-id pub-id-type="doi">10.1152/ajplung.90388.2008</pub-id></element-citation></ref>
<ref id="b12-br-0-0-1185"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbichler</surname><given-names>TB</given-names></name><name><surname>Metzler</surname><given-names>V</given-names></name><name><surname>Pritz</surname><given-names>C</given-names></name><name><surname>Riechelmann</surname><given-names>H</given-names></name><name><surname>Dudas</surname><given-names>J</given-names></name></person-group><article-title>Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells</article-title><source>Oncotarget</source><volume>7</volume><fpage>2508</fpage><lpage>2518</lpage><year>2016</year><pub-id pub-id-type="pmid">26497215</pub-id><pub-id pub-id-type="doi">10.18632/oncotarget.6210</pub-id></element-citation></ref>
<ref id="b13-br-0-0-1185"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juel</surname><given-names>HB</given-names></name><name><surname>Faber</surname><given-names>C</given-names></name><name><surname>Udsen</surname><given-names>MS</given-names></name><name><surname>Folkersen</surname><given-names>L</given-names></name><name><surname>Nissen</surname><given-names>MH</given-names></name></person-group><article-title>Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T cells</article-title><source>Invest Ophthalmol Vis Sci</source><volume>53</volume><fpage>8472</fpage><lpage>8480</lpage><year>2012</year><pub-id pub-id-type="pmid">23150618</pub-id><pub-id pub-id-type="doi">10.1167/iovs.12-9963</pub-id></element-citation></ref>
<ref id="b14-br-0-0-1185"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steelant</surname><given-names>B</given-names></name><name><surname>Seys</surname><given-names>SF</given-names></name><name><surname>Van Gerven</surname><given-names>L</given-names></name><name><surname>Van Woensel</surname><given-names>M</given-names></name><name><surname>Farre</surname><given-names>R</given-names></name><name><surname>Wawrzyniak</surname><given-names>P</given-names></name><name><surname>Kortekaas</surname><given-names>Krohn I</given-names></name><name><surname>Bullens</surname><given-names>DM</given-names></name><name><surname>Talavera</surname><given-names>K</given-names></name><name><surname>Raap</surname><given-names>U</given-names></name><etal/></person-group><article-title>Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis</article-title><source>J Allergy Clin Immunol</source><volume>141</volume><fpage>951</fpage><lpage>63</lpage><comment>e8</comment><year>2018</year><pub-id pub-id-type="pmid">29074456</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2017.08.039</pub-id></element-citation></ref>
<ref id="b15-br-0-0-1185"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koehler</surname><given-names>C</given-names></name><name><surname>Paulus</surname><given-names>M</given-names></name><name><surname>Ginzkey</surname><given-names>C</given-names></name><name><surname>Hackenberg</surname><given-names>S</given-names></name><name><surname>Scherzad</surname><given-names>A</given-names></name><name><surname>Ickrath</surname><given-names>P</given-names></name><name><surname>Hagen</surname><given-names>R</given-names></name><name><surname>Kleinsasser</surname><given-names>N</given-names></name></person-group><article-title>The Proinflammatory potential of nitrogen dioxide and its influence on the house dust mite allergen der p 1</article-title><source>Int Arch Allergy Immunol</source><volume>171</volume><fpage>27</fpage><lpage>35</lpage><year>2016</year><pub-id pub-id-type="pmid">27820923</pub-id><pub-id pub-id-type="doi">10.1159/000450751</pub-id></element-citation></ref>
<ref id="b16-br-0-0-1185"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koehler</surname><given-names>C</given-names></name><name><surname>Ginzkey</surname><given-names>C</given-names></name><name><surname>Friehs</surname><given-names>G</given-names></name><name><surname>Hackenberg</surname><given-names>S</given-names></name><name><surname>Froelich</surname><given-names>K</given-names></name><name><surname>Scherzed</surname><given-names>A</given-names></name><name><surname>Burghartz</surname><given-names>M</given-names></name><name><surname>Kessler</surname><given-names>M</given-names></name><name><surname>Kleinsasser</surname><given-names>N</given-names></name></person-group><article-title>Aspects of nitrogen dioxide toxicity in environmental urban concentrations in human nasal epithelium</article-title><source>Toxicol Appl Pharmacol</source><volume>245</volume><fpage>219</fpage><lpage>225</lpage><year>2010</year><pub-id pub-id-type="pmid">20214917</pub-id><pub-id pub-id-type="doi">10.1016/j.taap.2010.03.003</pub-id></element-citation></ref>
<ref id="b17-br-0-0-1185"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revenfeld</surname><given-names>AL</given-names></name><name><surname>Steffensen</surname><given-names>R</given-names></name><name><surname>Pugholm</surname><given-names>LH</given-names></name><name><surname>J&#x00F8;rgensen</surname><given-names>MM</given-names></name><name><surname>Stensballe</surname><given-names>A</given-names></name><name><surname>Varming</surname><given-names>K</given-names></name></person-group><article-title>Presence of HLA-DR Molecules and HLA-DRB1 mRNA in Circulating CD4(+) T Cells</article-title><source>Scand J Immunol</source><volume>84</volume><fpage>211</fpage><lpage>221</lpage><year>2016</year><pub-id pub-id-type="pmid">27417521</pub-id><pub-id pub-id-type="doi">10.1111/sji.12462</pub-id></element-citation></ref>
<ref id="b18-br-0-0-1185"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motamedi</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Elahi</surname><given-names>S</given-names></name></person-group><article-title>Correlation of transferrin receptor (CD71) with Ki67 expression on stimulated human and mouse T cells: The kinetics of expression of T cell activation markers</article-title><source>J Immunol Methods</source><volume>437</volume><fpage>43</fpage><lpage>52</lpage><year>2016</year><pub-id pub-id-type="pmid">27555239</pub-id><pub-id pub-id-type="doi">10.1016/j.jim.2016.08.002</pub-id></element-citation></ref>
<ref id="b19-br-0-0-1185"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>JH</given-names></name><name><surname>Moon</surname><given-names>HJ</given-names></name><name><surname>Seong</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Choi</surname><given-names>JY</given-names></name><name><surname>Song</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name></person-group><article-title>Mucociliary differentiation according to time in human nasal epithelial cell culture</article-title><source>Differentiation</source><volume>70</volume><fpage>77</fpage><lpage>83</lpage><year>2002</year><pub-id pub-id-type="pmid">12076334</pub-id><pub-id pub-id-type="doi">10.1046/j.1432-0436.2002.700202.x</pub-id></element-citation></ref>
<ref id="b20-br-0-0-1185"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bleier</surname><given-names>BS</given-names></name><name><surname>Mulligan</surname><given-names>RM</given-names></name><name><surname>Schlosser</surname><given-names>RJ</given-names></name></person-group><article-title>Primary human sinonasal epithelial cell culture model for topical drug delivery in patients with chronic rhinosinusitis with nasal polyposis</article-title><source>J Pharm Pharmacol</source><volume>64</volume><fpage>449</fpage><lpage>456</lpage><year>2012</year><pub-id pub-id-type="pmid">22309277</pub-id><pub-id pub-id-type="doi">10.1111/j.2042-7158.2011.01409.x</pub-id></element-citation></ref>
<ref id="b21-br-0-0-1185"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Borja</surname><given-names>Callejas F</given-names></name><name><surname>Mart&#x00ED;nez-Ant&#x00F3;n</surname><given-names>A</given-names></name><name><surname>Alobid</surname><given-names>I</given-names></name><name><surname>Fuentes</surname><given-names>M</given-names></name><name><surname>Cortijo</surname><given-names>J</given-names></name><name><surname>Picado</surname><given-names>C</given-names></name><name><surname>Roca-Ferrer</surname><given-names>J</given-names></name><name><surname>Mullol</surname><given-names>J</given-names></name></person-group><article-title>Reconstituted human upper airway epithelium as 3-d in vitro model for nasal polyposis</article-title><source>PLoS One</source><volume>9</volume><issue>e100537</issue><year>2014</year><pub-id pub-id-type="pmid">24945146</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0100537</pub-id></element-citation></ref>
<ref id="b22-br-0-0-1185"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divekar</surname><given-names>RD</given-names></name><name><surname>Samant</surname><given-names>S</given-names></name><name><surname>Rank</surname><given-names>MA</given-names></name><name><surname>Hagan</surname><given-names>J</given-names></name><name><surname>Lal</surname><given-names>D</given-names></name><name><surname>O&#x0027;Brien</surname><given-names>EK</given-names></name><name><surname>Kita</surname><given-names>H</given-names></name></person-group><article-title>Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations</article-title><source>Clin Exp Allergy</source><volume>45</volume><fpage>767</fpage><lpage>778</lpage><year>2015</year><pub-id pub-id-type="pmid">25429844</pub-id><pub-id pub-id-type="doi">10.1111/cea.12463</pub-id></element-citation></ref>
<ref id="b23-br-0-0-1185"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>M</given-names></name><name><surname>Sironi</surname><given-names>M</given-names></name><name><surname>Toniatti</surname><given-names>C</given-names></name><name><surname>Polentarutti</surname><given-names>N</given-names></name><name><surname>Fruscella</surname><given-names>P</given-names></name><name><surname>Ghezzi</surname><given-names>P</given-names></name><name><surname>Faggioni</surname><given-names>R</given-names></name><name><surname>Luini</surname><given-names>W</given-names></name><name><surname>van Hinsbergh</surname><given-names>V</given-names></name><name><surname>Sozzani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment</article-title><source>Immunity</source><volume>6</volume><fpage>315</fpage><lpage>325</lpage><year>1997</year><pub-id pub-id-type="pmid">9075932</pub-id><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80334-9</pub-id></element-citation></ref>
<ref id="b24-br-0-0-1185"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poposki</surname><given-names>JA</given-names></name><name><surname>Uzzaman</surname><given-names>A</given-names></name><name><surname>Nagarkar</surname><given-names>DR</given-names></name><name><surname>Chustz</surname><given-names>RT</given-names></name><name><surname>Peters</surname><given-names>AT</given-names></name><name><surname>Suh</surname><given-names>LA</given-names></name><name><surname>Carter</surname><given-names>R</given-names></name><name><surname>Norton</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>KE</given-names></name><name><surname>Grammer</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps</article-title><source>J Allergy Clin Immunol</source><volume>128</volume><fpage>73</fpage><lpage>81</lpage><comment>e4</comment><year>2011</year><pub-id pub-id-type="pmid">21497884</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2011.03.017</pub-id></element-citation></ref>
<ref id="b25-br-0-0-1185"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poposki</surname><given-names>JA</given-names></name><name><surname>Keswani</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Klingler</surname><given-names>AI</given-names></name><name><surname>Suh</surname><given-names>LA</given-names></name><name><surname>Norton</surname><given-names>J</given-names></name><name><surname>Carter</surname><given-names>RG</given-names></name><name><surname>Peters</surname><given-names>AT</given-names></name><name><surname>Hulse</surname><given-names>KE</given-names></name><name><surname>Grammer</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Tissue proteases convert CCL23 into potent monocyte chemoattractants in patients with chronic rhinosinusitis</article-title><source>J Allergy Clin Immunol</source><volume>137</volume><fpage>1274</fpage><lpage>1277</lpage><comment>e9</comment><year>2016</year><pub-id pub-id-type="pmid">26560043</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2015.09.029</pub-id></element-citation></ref>
<ref id="b26-br-0-0-1185"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Bruaene</surname><given-names>N</given-names></name><name><surname>Derycke</surname><given-names>L</given-names></name><name><surname>Perez-Novo</surname><given-names>CA</given-names></name><name><surname>Gevaert</surname><given-names>P</given-names></name><name><surname>Holtappels</surname><given-names>G</given-names></name><name><surname>De Ruyck</surname><given-names>N</given-names></name><name><surname>Cuvelier</surname><given-names>C</given-names></name><name><surname>Van Cauwenberge</surname><given-names>P</given-names></name><name><surname>Bachert</surname><given-names>C</given-names></name></person-group><article-title>TGF-beta signaling and collagen deposition in chronic rhinosinusitis</article-title><source>J Allergy Clin Immunol</source><volume>124</volume><fpage>253</fpage><lpage>9</lpage><comment>259.e1-2</comment><year>2009</year><pub-id pub-id-type="pmid">19500825</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2009.04.013</pub-id></element-citation></ref>
<ref id="b27-br-0-0-1185"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pant</surname><given-names>H</given-names></name><name><surname>Hughes</surname><given-names>A</given-names></name><name><surname>Miljkovic</surname><given-names>D</given-names></name><name><surname>Schembri</surname><given-names>M</given-names></name><name><surname>Wormald</surname><given-names>P</given-names></name><name><surname>Macardle</surname><given-names>P</given-names></name><name><surname>Grose</surname><given-names>R</given-names></name><name><surname>Zola</surname><given-names>H</given-names></name><name><surname>Krumbiegel</surname><given-names>D</given-names></name></person-group><article-title>Accumulation of effector memory CD8+ T cells in nasal polyps</article-title><source>Am J Rhinol Allergy</source><volume>27</volume><fpage>e117</fpage><lpage>e126</lpage><year>2013</year><pub-id pub-id-type="pmid">24119592</pub-id><pub-id pub-id-type="doi">10.2500/ajra.2013.27.3958</pub-id></element-citation></ref>
<ref id="b28-br-0-0-1185"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>OH</given-names></name><name><surname>McSorley</surname><given-names>SJ</given-names></name></person-group><article-title>Divergent behavior of mucosal memory T cells</article-title><source>Mucosal Immunol</source><volume>8</volume><fpage>731</fpage><lpage>734</lpage><year>2015</year><pub-id pub-id-type="pmid">26059005</pub-id><pub-id pub-id-type="doi">10.1038/mi.2015.52</pub-id></element-citation></ref>
<ref id="b29-br-0-0-1185"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>FR</given-names></name></person-group><article-title>Tissue-resident memory T cells and fixed immune surveillance in nonlymphoid organs</article-title><source>J Immunol</source><volume>195</volume><fpage>17</fpage><lpage>22</lpage><year>2015</year><pub-id pub-id-type="pmid">26092813</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1500515</pub-id></element-citation></ref>
<ref id="b30-br-0-0-1185"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ely</surname><given-names>KH</given-names></name><name><surname>Cauley</surname><given-names>LS</given-names></name><name><surname>Roberts</surname><given-names>AD</given-names></name><name><surname>Brennan</surname><given-names>JW</given-names></name><name><surname>Cookenham</surname><given-names>T</given-names></name><name><surname>Woodland</surname><given-names>DL</given-names></name></person-group><article-title>Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections</article-title><source>J Immunol</source><volume>170</volume><fpage>1423</fpage><lpage>1429</lpage><year>2003</year><pub-id pub-id-type="pmid">12538703</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.170.3.1423</pub-id></element-citation></ref>
<ref id="b31-br-0-0-1185"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>S</given-names></name></person-group><article-title>Der Experimentator: Zellkultur</article-title><source>Spektrum Akademischer Verlag, Heidelberg</source><year>2011</year></element-citation></ref>
<ref id="b32-br-0-0-1185"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gstraunthaler</surname><given-names>G</given-names></name><name><surname>Lindl</surname><given-names>T</given-names></name></person-group><article-title>Zell- und Gewebekultur: Allgemeine Grundlagen und spezielle Anwendungen</article-title><source>Springer Spektrum Akademischer Verlag, Heidelberg</source><year>2013</year></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-br-0-0-1185" position="float">
<label>Figure 1</label>
<caption><p>Dot blot assay to semi-quantitatively assess secreted cytokines in the supernatant of polypoid tissue. (A) Representative dot blot assay of the supernatant of a single model after 3 days of culture: In this example, a predominant secretion of IL-6 and GM-CSF was detected. (B) Density of IL-6, IL-6R, GM-CSF, TGF-&#x03B2; and MIP-3 of 4 from the 16 total cultures in comparison to the positive control measured by ImageJ software. Every culture was measured twice. IL-6, interleukin-6; IL-6R, interleukin-6 receptor; GM-CSF, granulocyte-macrophage colony-stimulating factor; MIP-3, macrophage inflammatory protein-3; TGF-&#x03B2;, transforming growth factor-&#x03B2;.</p></caption>
<graphic xlink:href="br-10-02-0119-g00.tiff"/>
</fig>
<fig id="f2-br-0-0-1185" position="float">
<label>Figure 2</label>
<caption><p>Comparison of CD3<sup>+</sup> T cell viability between mono- and co-culture. (A and B) Frequencies of viable CD3<sup>+</sup> T cells in (A) mono-culture and (B) co-culture after 3 days detected by staining with VD780; (C) comparison of viable CD3<sup>+</sup> T cell frequencies between mono- and a co-culture; frequencies of (D) CD4<sup>+</sup> and (E) CD8<sup>+</sup> T cells in mono-culture compared with co-culture. Data are presented as the means &#x00B1; standard deviation (n=16). <sup>*</sup>P&#x003C;0.05 and <sup>***</sup>P&#x003C;0.001 CD, cluster of differentiation; VD780, viability dye 780.</p></caption>
<graphic xlink:href="br-10-02-0119-g01.tiff"/>
</fig>
<fig id="f3-br-0-0-1185" position="float">
<label>Figure 3</label>
<caption><p>Frequencies of CD3<sup>+</sup>CD4<sup>+</sup> T cells in mono- and co-culture. (A) T<sub>reg</sub> subpopulations in co-culture compared with mono-culture. Shown are the frequencies of CD4<sup>+</sup> resting T<sub>regs</sub>, activated T<sub>regs</sub>, FoxP3<sub>low</sub> memory T cells (T<sub>conv</sub>), FoxP3<sup>-</sup> memory T cells (T<sub>conv</sub>) and na&#x00EF;ve T cells. (B) Expression of HLA-DR on CD3<sup>+</sup>CD4<sup>+</sup> T cells in mono- and co-culture. Data are presented as the mean &#x00B1; standard deviation (n=16) <sup>****</sup>P&#x003C;0.0001; CD, cluster of differentiation; T<sub>regs</sub>, regulatory T cells; FoxP3, Forkhead box P3; HLA-DR, human leukocyte antigen-DR isotype.</p></caption>
<graphic xlink:href="br-10-02-0119-g02.tiff"/>
</fig>
<table-wrap id="tI-br-0-0-1185" position="float">
<label>Table I.</label>
<caption><p>CD3<sup>+</sup> T cell subpopulations.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">T cell subpopulation</th>
<th align="center" valign="middle">Co-culture</th>
<th align="center" valign="middle">Mono-culture</th>
<th align="center" valign="middle">P-value<sup><xref rid="tfn1-br-0-0-1185" ref-type="table-fn">a</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">CD4<sup>+</sup></td>
<td align="center" valign="middle">33.83&#x00B1;14.39</td>
<td align="center" valign="middle">28.28&#x00B1;17.03</td>
<td align="center" valign="middle">0.02</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>-</sup>CCR7<sup>-</sup> effector memory</td>
<td align="center" valign="middle">52.26&#x00B1;21.38</td>
<td align="center" valign="middle">54.19&#x00B1;21.58</td>
<td align="center" valign="middle">0.59</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>+</sup>CCR7<sup>-</sup> terminally differentiated</td>
<td align="center" valign="middle">18.72&#x00B1;17.11</td>
<td align="center" valign="middle">23.02&#x00B1;19.07</td>
<td align="center" valign="middle">0.18</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>-</sup>CCR7<sup>+</sup> central memory</td>
<td align="center" valign="middle">12.02&#x00B1;9.72</td>
<td align="center" valign="middle">9.48&#x00B1;10.00</td>
<td align="center" valign="middle">0.12</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>+</sup>CCR7<sup>+</sup> na&#x00EF;ve</td>
<td align="center" valign="middle">17.17&#x00B1;14.50</td>
<td align="center" valign="middle">13.71&#x00B1;15.62</td>
<td align="center" valign="middle">0.23</td>
</tr>
<tr>
<td align="left" valign="middle">CD8<sup>+</sup></td>
<td align="center" valign="middle">22.36&#x00B1;8.94</td>
<td align="center" valign="middle">15.60&#x00B1;8.42</td>
<td align="center" valign="middle">0.0008</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>-</sup>CCR7<sup>-</sup> effector memory</td>
<td align="center" valign="middle">44.98&#x00B1;20.43</td>
<td align="center" valign="middle">44.28&#x00B1;22.95</td>
<td align="center" valign="middle">0.83</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>+</sup>CCR7<sup>-</sup> terminally differentiated</td>
<td align="center" valign="middle">33.46&#x00B1;20.45</td>
<td align="center" valign="middle">32.72&#x00B1;21.77</td>
<td align="center" valign="middle">0.56</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>-</sup>CCR7<sup>+</sup> central memory</td>
<td align="center" valign="middle">7.74&#x00B1;11.97</td>
<td align="center" valign="middle">9.60&#x00B1;12.35</td>
<td align="center" valign="middle">0.25</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;CD45RA<sup>+</sup>CCR7<sup>+</sup> na&#x00EF;ve</td>
<td align="center" valign="middle">13.36&#x00B1;15.73</td>
<td align="center" valign="middle">12.78&#x00B1;12.19</td>
<td align="center" valign="middle">0.78</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-br-0-0-1185"><p>Data are presented as the mean &#x00B1; standard deviation (n=16). <sup>a</sup>Paired t-test for parametric distribution, Wilcoxon test for non-parametric distribution. CD, cluster of differentiation; CCR7, C-C motif chemokine receptor type 7.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-br-0-0-1185" position="float">
<label>Table II.</label>
<caption><p>Treg subpopulations analyzed by staining for CD4, CD45RA and FoxP3.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">CD3<sup>+</sup>CD4<sup>+</sup> cell subpopulation</th>
<th align="center" valign="middle">Co-culture</th>
<th align="center" valign="middle">Mono-culture</th>
<th align="center" valign="middle">P-value<sup><xref rid="tfn2-br-0-0-1185" ref-type="table-fn">a</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">CD45RA<sup>+</sup>FoxP3<sup>low</sup>CTLA-4<sup>low</sup> resting T<sub>regs</sub></td>
<td align="center" valign="middle">5.70&#x00B1;2.05</td>
<td align="center" valign="middle">11.40&#x00B1;9.63</td>
<td align="center" valign="middle">0.01</td>
</tr>
<tr>
<td align="left" valign="middle">CD45RA<sup>-</sup>FoxP3<sup>high</sup>CTLA-4<sup>high</sup> activated T<sub>regs</sub></td>
<td align="center" valign="middle">4.75&#x00B1;2.78</td>
<td align="center" valign="middle">3.07&#x00B1;3.05</td>
<td align="center" valign="middle">0.04</td>
</tr>
<tr>
<td align="left" valign="middle">CD45RA<sup>-</sup>Foxp3<sup>low</sup> memory cells (T<sub>conv</sub>)</td>
<td align="center" valign="middle">8.42&#x00B1;3.82</td>
<td align="center" valign="middle">7.25&#x00B1;5.40</td>
<td align="center" valign="middle">0.50</td>
</tr>
<tr>
<td align="left" valign="middle">CD45RA<sup>-</sup>Foxp3<sup>-</sup> memory cells (T<sub>conv</sub>)</td>
<td align="center" valign="middle">37.93&#x00B1;11.41</td>
<td align="center" valign="middle">30.13&#x00B1;14.17</td>
<td align="center" valign="middle">0.01</td>
</tr>
<tr>
<td align="left" valign="middle">CD45RA<sup>+</sup>Foxp3<sup>-</sup> na&#x00EF;ve T cells</td>
<td align="center" valign="middle">42.40&#x00B1;15.52</td>
<td align="center" valign="middle">46.64&#x00B1;17.43</td>
<td align="center" valign="middle">0.23</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-br-0-0-1185"><p>Data are presented as the mean &#x00B1; standard deviation (n=16). <sup>a</sup>Paired t-test for parametric distribution, Wilcoxon test for non-parametric distribution. CD, cluster of differentiation; T<sub>regs</sub>, regulatory T cells; T<sub>conv</sub>, conventional T cells; FoxP3, Forkhead box P3; CTLA-4, cytotoxic T-lymphocyte.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-br-0-0-1185" position="float">
<label>Table III.</label>
<caption><p>Detection of T cells expressing the activation markers HLA-DR and Ki-67.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">T cell</th>
<th align="center" valign="middle">Co-culture</th>
<th align="center" valign="middle">Mono-culture</th>
<th align="center" valign="middle">P-value<sup><xref rid="tfn3-br-0-0-1185" ref-type="table-fn">a</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" colspan="4">CD3<sup>+</sup> T cells</td>
</tr>
<tr>
<td align="left" valign="middle">HLA-DR<sup>+</sup></td>
<td align="center" valign="middle">7.74&#x00B1;5.06</td>
<td align="center" valign="middle">17.42&#x00B1;14.86</td>
<td align="center" valign="middle">0.01</td>
</tr>
<tr>
<td align="left" valign="middle">Ki-67<sup>+</sup></td>
<td align="center" valign="middle">47.30&#x00B1;25.62</td>
<td align="center" valign="middle">38.46&#x00B1;26.51</td>
<td align="center" valign="middle">0.22</td>
</tr>
<tr>
<td align="left" valign="middle" colspan="4">CD4<sup>+</sup> T cells</td>
</tr>
<tr>
<td align="left" valign="middle">HLA-DR<sup>+</sup></td>
<td align="center" valign="middle">8.55&#x00B1;8.05</td>
<td align="center" valign="middle">23.10&#x00B1;20.43</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="middle">Ki-67<sup>+</sup></td>
<td align="center" valign="middle">53.99&#x00B1;25.66</td>
<td align="center" valign="middle">55.03&#x00B1;36.25</td>
<td align="center" valign="middle">0.88</td>
</tr>
<tr>
<td align="left" valign="middle" colspan="4">CD8<sup>+</sup> T cells</td>
</tr>
<tr>
<td align="left" valign="middle">Ki-67<sup>+</sup></td>
<td align="center" valign="middle">62.17&#x00B1;30.52</td>
<td align="center" valign="middle">55.93&#x00B1;35.16</td>
<td align="center" valign="middle">0.71</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-br-0-0-1185"><p>Data are presented as the mean &#x00B1; standard deviation (n=16). <sup>a</sup>Paired t-test for parametric distribution, Wilcoxon test for non-parametric distribution. CD, cluster of differentiation; HLA-DR, human leukocyte antigen-DR isotype.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
